![Why Did Tesla Stock [TSLA] Rise Again?](https://cleantechnica.com/wp-content/uploads/2025/04/Screenshot-2025-04-10-at-3.31.36 AM.png)
Abeona cell therapy approved by FDA for rare skin condition
Zevaskyn, which Abeona priced at $3.1 million, treats epidermolysis bullosa. It will compete with a gene therapy from Krystal Biotech that is off to a strong sales start.
Zevaskyn, which Abeona priced at $3.1 million, treats epidermolysis bullosa. It will compete with a gene therapy from Krystal Biotech that is off to a strong sales start.
